Selected research
Industry Research
Male Infertility Treatment Industry Research Report 2026
Market perspective
The global Male Infertility Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Male Infertility Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Male Infertility Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Male Infertility Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Male Infertility Treatment include Zhejiang Xianju Pharmaceutical Co.,Ltd., Church & Dwight, Livzon Pharmaceutical Group Inc., Eli Lilly and Company, GeneScience Pharmaceuticals Co., Ltd., Bayer, Bristol Myers Squibb, SCSA diagnostics and Merck Serono, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Male Infertility Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Male Infertility Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Male Infertility Treatment Market by Company
Zhejiang Xianju Pharmaceutical Co.,Ltd.
Church & Dwight
Livzon Pharmaceutical Group Inc.
Eli Lilly and Company
GeneScience Pharmaceuticals Co., Ltd.
Bayer
Bristol Myers Squibb
SCSA diagnostics
Merck Serono
Intas Pharma
Intas Biopharmaceuticals
Halotech DNA
Cadila
Aytu BioScience
ASKA Pharmaceutical Co., Ltd.
Andrology Solutions
Abeona Therapeutics Inc.
Male Infertility Treatment Segment by Type
Oxidative Stress Analysis
Microscopic Examination
Sperm Agglutination
Sperm Penetration Assay
DNA Fragmentation Technique
Computer Assisted Semen Analysis
Male Infertility Treatment Segment by Application
Hospitals
Clinics
Others
Male Infertility Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Male Infertility Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Male Infertility Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Male Infertility Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Male Infertility Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oxidative Stress Analysis
- Microscopic Examination
- Sperm Agglutination
- Sperm Penetration Assay
- DNA Fragmentation Technique
- Computer Assisted Semen Analysis
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Zhejiang Xianju Pharmaceutical Co.,Ltd.
- Church & Dwight
- Livzon Pharmaceutical Group Inc.
- Eli Lilly and Company
- GeneScience Pharmaceuticals Co., Ltd.
- Bayer
- Bristol Myers Squibb
- SCSA diagnostics
- Merck Serono
- Intas Pharma
- Intas Biopharmaceuticals
- Halotech DNA
- Cadila
- Aytu BioScience
- ASKA Pharmaceutical Co., Ltd.
- Andrology Solutions
- Abeona Therapeutics Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Male Infertility Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Oxidative Stress Analysis
- 2.2.3 Microscopic Examination
- 2.2.4 Sperm Agglutination
- 2.2.5 Sperm Penetration Assay
- 2.2.6 DNA Fragmentation Technique
- 2.2.7 Computer Assisted Semen Analysis
- 2.3 Male Infertility Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Clinics
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Male Infertility Treatment Breakdown Data by Type
- 3.1 Global Male Infertility Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Male Infertility Treatment Forecasted Market Size by Type (2027-2032)
4 Male Infertility Treatment Breakdown Data by Application
- 4.1 Global Male Infertility Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Male Infertility Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Male Infertility Treatment Market Perspective (2021-2032)
- 5.2 Global Male Infertility Treatment Growth Trends by Region
- 5.2.1 Global Male Infertility Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Male Infertility Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Male Infertility Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Male Infertility Treatment Market Dynamics
- 5.3.1 Male Infertility Treatment Industry Trends
- 5.3.2 Male Infertility Treatment Market Drivers
- 5.3.3 Male Infertility Treatment Market Challenges
- 5.3.4 Male Infertility Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Male Infertility Treatment Players by Revenue
- 6.1.1 Global Top Male Infertility Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Male Infertility Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Male Infertility Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Male Infertility Treatment Head Office and Area Served
- 6.4 Global Male Infertility Treatment Players, Product Type & Application
- 6.5 Global Male Infertility Treatment Manufacturers Established Date
- 6.6 Global Male Infertility Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Male Infertility Treatment Market Size (2021-2032)
- 7.2 North America Male Infertility Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Male Infertility Treatment Market Size by Country (2021-2026)
- 7.4 North America Male Infertility Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Male Infertility Treatment Market Size (2021-2032)
- 8.2 Europe Male Infertility Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Male Infertility Treatment Market Size by Country (2021-2026)
- 8.4 Europe Male Infertility Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Male Infertility Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Male Infertility Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Male Infertility Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Male Infertility Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Male Infertility Treatment Market Size (2021-2032)
- 10.2 South America Male Infertility Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Male Infertility Treatment Market Size by Country (2021-2026)
- 10.4 South America Male Infertility Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Male Infertility Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Male Infertility Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Male Infertility Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Male Infertility Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Zhejiang Xianju Pharmaceutical Co.,Ltd.
- 12.1.1 Zhejiang Xianju Pharmaceutical Co.,Ltd. Company Information
- 12.1.2 Zhejiang Xianju Pharmaceutical Co.,Ltd. Business Overview
- 12.1.3 Zhejiang Xianju Pharmaceutical Co.,Ltd. Revenue in Male Infertility Treatment Business (2021-2026)
- 12.1.4 Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Product Portfolio
- 12.1.5 Zhejiang Xianju Pharmaceutical Co.,Ltd. Recent Developments
- 12.2 Church & Dwight
- 12.2.1 Church & Dwight Company Information
- 12.2.2 Church & Dwight Business Overview
- 12.2.3 Church & Dwight Revenue in Male Infertility Treatment Business (2021-2026)
- 12.2.4 Church & Dwight Male Infertility Treatment Product Portfolio
- 12.2.5 Church & Dwight Recent Developments
- 12.3 Livzon Pharmaceutical Group Inc.
- 12.3.1 Livzon Pharmaceutical Group Inc. Company Information
- 12.3.2 Livzon Pharmaceutical Group Inc. Business Overview
- 12.3.3 Livzon Pharmaceutical Group Inc. Revenue in Male Infertility Treatment Business (2021-2026)
- 12.3.4 Livzon Pharmaceutical Group Inc. Male Infertility Treatment Product Portfolio
- 12.3.5 Livzon Pharmaceutical Group Inc. Recent Developments
- 12.4 Eli Lilly and Company
- 12.4.1 Eli Lilly and Company Company Information
- 12.4.2 Eli Lilly and Company Business Overview
- 12.4.3 Eli Lilly and Company Revenue in Male Infertility Treatment Business (2021-2026)
- 12.4.4 Eli Lilly and Company Male Infertility Treatment Product Portfolio
- 12.4.5 Eli Lilly and Company Recent Developments
- 12.5 GeneScience Pharmaceuticals Co., Ltd.
- 12.5.1 GeneScience Pharmaceuticals Co., Ltd. Company Information
- 12.5.2 GeneScience Pharmaceuticals Co., Ltd. Business Overview
- 12.5.3 GeneScience Pharmaceuticals Co., Ltd. Revenue in Male Infertility Treatment Business (2021-2026)
- 12.5.4 GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Product Portfolio
- 12.5.5 GeneScience Pharmaceuticals Co., Ltd. Recent Developments
- 12.6 Bayer
- 12.6.1 Bayer Company Information
- 12.6.2 Bayer Business Overview
- 12.6.3 Bayer Revenue in Male Infertility Treatment Business (2021-2026)
- 12.6.4 Bayer Male Infertility Treatment Product Portfolio
- 12.6.5 Bayer Recent Developments
- 12.7 Bristol Myers Squibb
- 12.7.1 Bristol Myers Squibb Company Information
- 12.7.2 Bristol Myers Squibb Business Overview
- 12.7.3 Bristol Myers Squibb Revenue in Male Infertility Treatment Business (2021-2026)
- 12.7.4 Bristol Myers Squibb Male Infertility Treatment Product Portfolio
- 12.7.5 Bristol Myers Squibb Recent Developments
- 12.8 SCSA diagnostics
- 12.8.1 SCSA diagnostics Company Information
- 12.8.2 SCSA diagnostics Business Overview
- 12.8.3 SCSA diagnostics Revenue in Male Infertility Treatment Business (2021-2026)
- 12.8.4 SCSA diagnostics Male Infertility Treatment Product Portfolio
- 12.8.5 SCSA diagnostics Recent Developments
- 12.9 Merck Serono
- 12.9.1 Merck Serono Company Information
- 12.9.2 Merck Serono Business Overview
- 12.9.3 Merck Serono Revenue in Male Infertility Treatment Business (2021-2026)
- 12.9.4 Merck Serono Male Infertility Treatment Product Portfolio
- 12.9.5 Merck Serono Recent Developments
- 12.10 Intas Pharma
- 12.10.1 Intas Pharma Company Information
- 12.10.2 Intas Pharma Business Overview
- 12.10.3 Intas Pharma Revenue in Male Infertility Treatment Business (2021-2026)
- 12.10.4 Intas Pharma Male Infertility Treatment Product Portfolio
- 12.10.5 Intas Pharma Recent Developments
- 12.11 Intas Biopharmaceuticals
- 12.11.1 Intas Biopharmaceuticals Company Information
- 12.11.2 Intas Biopharmaceuticals Business Overview
- 12.11.3 Intas Biopharmaceuticals Revenue in Male Infertility Treatment Business (2021-2026)
- 12.11.4 Intas Biopharmaceuticals Male Infertility Treatment Product Portfolio
- 12.11.5 Intas Biopharmaceuticals Recent Developments
- 12.12 Halotech DNA
- 12.12.1 Halotech DNA Company Information
- 12.12.2 Halotech DNA Business Overview
- 12.12.3 Halotech DNA Revenue in Male Infertility Treatment Business (2021-2026)
- 12.12.4 Halotech DNA Male Infertility Treatment Product Portfolio
- 12.12.5 Halotech DNA Recent Developments
- 12.13 Cadila
- 12.13.1 Cadila Company Information
- 12.13.2 Cadila Business Overview
- 12.13.3 Cadila Revenue in Male Infertility Treatment Business (2021-2026)
- 12.13.4 Cadila Male Infertility Treatment Product Portfolio
- 12.13.5 Cadila Recent Developments
- 12.14 Aytu BioScience
- 12.14.1 Aytu BioScience Company Information
- 12.14.2 Aytu BioScience Business Overview
- 12.14.3 Aytu BioScience Revenue in Male Infertility Treatment Business (2021-2026)
- 12.14.4 Aytu BioScience Male Infertility Treatment Product Portfolio
- 12.14.5 Aytu BioScience Recent Developments
- 12.15 ASKA Pharmaceutical Co., Ltd.
- 12.15.1 ASKA Pharmaceutical Co., Ltd. Company Information
- 12.15.2 ASKA Pharmaceutical Co., Ltd. Business Overview
- 12.15.3 ASKA Pharmaceutical Co., Ltd. Revenue in Male Infertility Treatment Business (2021-2026)
- 12.15.4 ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Product Portfolio
- 12.15.5 ASKA Pharmaceutical Co., Ltd. Recent Developments
- 12.16 Andrology Solutions
- 12.16.1 Andrology Solutions Company Information
- 12.16.2 Andrology Solutions Business Overview
- 12.16.3 Andrology Solutions Revenue in Male Infertility Treatment Business (2021-2026)
- 12.16.4 Andrology Solutions Male Infertility Treatment Product Portfolio
- 12.16.5 Andrology Solutions Recent Developments
- 12.17 Abeona Therapeutics Inc.
- 12.17.1 Abeona Therapeutics Inc. Company Information
- 12.17.2 Abeona Therapeutics Inc. Business Overview
- 12.17.3 Abeona Therapeutics Inc. Revenue in Male Infertility Treatment Business (2021-2026)
- 12.17.4 Abeona Therapeutics Inc. Male Infertility Treatment Product Portfolio
- 12.17.5 Abeona Therapeutics Inc. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst